Karbapenem resistant Enterobacteriaceae term refers to the CRE karbapenemam-resistant and carbapenemase producing Enterobacteriaceae. Currently, the most common type of carbapenemase in the United States
Klebsiella pneumonia carbapenemase (KPC). In 2010 carbapenemases known as metallo-beta-lactamase (Mbl) were first discovered in the United States: New Delhi MBL (known as NDM-1) and Verona integrones encoded MBL (known as VIM). CRE facts including: CRE, which is as common CRE, and how to prevent strattera side effects CRE. Information for health professionals about the resistance mechanisms responsible for the CRE. CRE definition of observation and reporting MDH. Laboratory testing protocols CRE and isolate submission MDH. MDH recommendations for prevention and control of persistent karbapenemov Enterobacteriaceae (CRE) or carbapenemase producing Enterobacteriaceae in acute and long-term acute care. Management, publications and resources to prevent CRE transmission in health facilities. .
No comments:
Post a Comment